These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7722794)

  • 1. Molecular approaches to identify novel targets for future development of antifungal agents.
    Maresca B; Bennett J; Fonzi W; Hitchcock CA; Lodge JK; Williamson PR
    J Med Vet Mycol; 1994; 32 Suppl 1():287-98. PubMed ID: 7722794
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of azole-responsive genes by microarray technology: why are we missing the efflux transporter genes?
    Kontoyiannis DP; May GS
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3674-6. PubMed ID: 11724035
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of myristoyl-CoA:protein N-myristoyltransferases from three pathogenic fungi: Cryptococcus neoformans, Histoplasma capsulatum, and Candida albicans.
    Lodge JK; Johnson RL; Weinberg RA; Gordon JI
    J Biol Chem; 1994 Jan; 269(4):2996-3009. PubMed ID: 8300631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biochemistry of azole derivatives and the problem of drug resistance].
    Kerridge D; Parker S
    Ann Dermatol Venereol; 1989; 116 Suppl 1():7-9. PubMed ID: 2688527
    [No Abstract]   [Full Text] [Related]  

  • 5. Human salivary histatin-5 exerts potent fungicidal activity against Cryptococcus neoformans.
    Tsai H; Bobek LA
    Biochim Biophys Acta; 1997 Oct; 1336(3):367-9. PubMed ID: 9367163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic studies on the mode of action of azole antifungal agents.
    Kelly SL; Rowe J; Watson PF
    Biochem Soc Trans; 1991 Aug; 19(3):796-8. PubMed ID: 1783219
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolation and in vitro antifungal activity of 6,6'-dihydroxythiobinupharidine.
    Cullen WP; LaLonde RT; Wang CJ; Wong CF
    J Pharm Sci; 1973 May; 62(5):826-7. PubMed ID: 4574588
    [No Abstract]   [Full Text] [Related]  

  • 8. Khafrefungin, a novel inhibitor of sphingolipid synthesis.
    Mandala SM; Thornton RA; Rosenbach M; Milligan J; Garcia-Calvo M; Bull HG; Kurtz MB
    J Biol Chem; 1997 Dec; 272(51):32709-14. PubMed ID: 9405490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Y118 amino acid residue in Candida albicans sterol 14alpha-demethylase associated with the enzyme activity and selective antifungal activity of azole analogues.
    Chen SH; Sheng CQ; Xu XH; Jiang YY; Zhang WN; He C
    Biol Pharm Bull; 2007 Jul; 30(7):1246-53. PubMed ID: 17603162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondria and fungal pathogenesis: drug tolerance, virulence, and potential for antifungal therapy.
    Shingu-Vazquez M; Traven A
    Eukaryot Cell; 2011 Nov; 10(11):1376-83. PubMed ID: 21926328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR.
    Cruz MC; Goldstein AL; Blankenship J; Del Poeta M; Perfect JR; McCusker JH; Bennani YL; Cardenas ME; Heitman J
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3162-70. PubMed ID: 11600372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal effects of vitamin K3 on Cryptococcus neoformans and Candida albicans.
    Jen TM
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 Aug; 15(3):250-2. PubMed ID: 6754288
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular Evolution of Antifungal Drug Resistance.
    Robbins N; Caplan T; Cowen LE
    Annu Rev Microbiol; 2017 Sep; 71():753-775. PubMed ID: 28886681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antifungal activity of coumarins and angular furanocoumarins.
    Sardari S; Mori Y; Horita K; Micetich RG; Nishibe S; Daneshtalab M
    Bioorg Med Chem; 1999 Sep; 7(9):1933-40. PubMed ID: 10530942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling, synthesis and biological activity of novel antifungal agents (1).
    Tsukuda T; Shiratori Y; Watanabe M; Ontsuka H; Hattori K; Shirai M; Shimma N
    Bioorg Med Chem Lett; 1998 Jul; 8(14):1819-24. PubMed ID: 9873440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
    Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-oxatetradecanoic acid is fungicidal for Cryptococcus neoformans and inhibits replication of human immunodeficiency virus I.
    Langner CA; Lodge JK; Travis SJ; Caldwell JE; Lu T; Li Q; Bryant ML; Devadas B; Gokel GW; Kobayashi GS
    J Biol Chem; 1992 Aug; 267(24):17159-69. PubMed ID: 1512254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidating drug resistance in human fungal pathogens.
    Xie JL; Polvi EJ; Shekhar-Guturja T; Cowen LE
    Future Microbiol; 2014; 9(4):523-42. PubMed ID: 24810351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioassay-guided isolation of antifungal alkaloids from Melochia odorata.
    Emile A; Waikedre J; Herrenknecht C; Fourneau C; Gantier JC; Hnawia E; Cabalion P; Hocquemiller R; Fournet A
    Phytother Res; 2007 Apr; 21(4):398-400. PubMed ID: 17236172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antifungal and antibiofilm activities of halogenated quinoline analogues against Candida albicans and Cryptococcus neoformans.
    Zuo R; Garrison AT; Basak A; Zhang P; Huigens RW; Ding Y
    Int J Antimicrob Agents; 2016 Aug; 48(2):208-11. PubMed ID: 27256584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.